These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34680065)

  • 1. Circulating MicroRNAs as Novel Potential Diagnostic Biomarkers for Osteosarcoma: A Systematic Review.
    Gally TB; Aleluia MM; Borges GF; Kaneto CM
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis.
    Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X
    Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.
    Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C
    Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
    Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
    Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
    Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis.
    Zhang WT; Zhang GX; Gao SS
    Technol Cancer Res Treat; 2021; 20():15330338211011958. PubMed ID: 33902358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma.
    Ouyang L; Liu P; Yang S; Ye S; Xu W; Liu X
    Med Oncol; 2013 Mar; 30(1):340. PubMed ID: 23269581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
    Lian F; Cui Y; Zhou C; Gao K; Wu L
    PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
    Lamichhane SR; Thachil T; Gee H; Milic N
    Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
    Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
    Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of serum miR-194 predicts poor prognosis in osteosarcoma patients.
    Shi L; Xie C; Zhu J; Chen X
    Ann Diagn Pathol; 2020 Jun; 46():151488. PubMed ID: 32172218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Plasma MicroRNA Signature in Osteosarcoma Patients.
    Allen-Rhoades W; Yustein JT
    Methods Mol Biol; 2018; 1699():113-118. PubMed ID: 29086373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Liquid Biopsy in the Treatment of Patient with OS.
    Shulman DS; Crompton BD
    Adv Exp Med Biol; 2020; 1257():95-105. PubMed ID: 32483734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in osteosarcoma.
    Zhang J; Yan YG; Wang C; Zhang SJ; Yu XH; Wang WJ
    Clin Chim Acta; 2015 Apr; 444():9-17. PubMed ID: 25661090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNAs as circulating biomarkers in osteosarcoma patients.
    Botti G; Giordano A; Feroce F; De Chiara AR; Cantile M
    J Cell Physiol; 2019 Nov; 234(11):19249-19255. PubMed ID: 31032924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
    Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
    J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples.
    Liu HP; Lai HM; Guo Z
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32607548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.